1. Home
  2. SKWD vs FTRE Comparison

SKWD vs FTRE Comparison

Compare SKWD & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyward Specialty Insurance Group Inc.

SKWD

Skyward Specialty Insurance Group Inc.

HOLD

Current Price

$42.97

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.82

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKWD
FTRE
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
SKWD
FTRE
Price
$42.97
$9.82
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$65.33
$15.39
AVG Volume (30 Days)
492.8K
1.6M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
41.81
N/A
EPS
4.07
N/A
Revenue
$1,416,541,000.00
$2,723,400,000.00
Revenue This Year
$30.81
N/A
Revenue Next Year
$12.09
$3.01
P/E Ratio
$10.11
N/A
Revenue Growth
23.16
1.00
52 Week Low
$40.60
$3.97
52 Week High
$65.05
$18.67

Technical Indicators

Market Signals
Indicator
SKWD
FTRE
Relative Strength Index (RSI) 40.87 41.99
Support Level N/A $9.05
Resistance Level $49.64 $11.22
Average True Range (ATR) 1.38 0.64
MACD -0.55 0.22
Stochastic Oscillator 26.16 55.28

Price Performance

Historical Comparison
SKWD
FTRE

About SKWD Skyward Specialty Insurance Group Inc.

Skyward Specialty Insurance Group Inc is a specialty insurance company that offers a suite of specialized insurance solutions across specialty property and casualty markets on a non-admitted and admitted basis. Its portfolio of insurance offerings covers a wide variety of risks, including general liability, commercial auto, group accident and health, property, agriculture, credit, surety, and workers' compensation, among others. Geographically, the group mainly operates in the United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: